December
Out in the open
How have the changes in the disclosure of clinical trial results impacted on med comms?...
08 Dec 2010
The holy grail
Gain a competitive advantage by developing an effective digital listening strategy...
23 Dec 2010
CME opportunity
There is a place for the right form of commercial educational support...
16 Dec 2010
Novartis to lay off 1,400 US sales reps
Novartis is laying off 1,400 US sales reps in its general medicines force to reflect changes in its product portfolio as a result of patent expirations and planned product launches
01 Dec 2010
J&J expects Crucell offer within days
J&J has said it expects to receive regulatory clearance and commence its offer for the Dutch vaccine maker Crucell before December 10, when an Extraordinary General Meeting of Crucell shareholders is scheduled
01 Dec 2010
Genzyme sells genetics unit to LabCorp
US-based biotech, Genzyme Corporation, has completed the sale of its genetics business to Laboratory Corporation of America Holdings for $925m in cash
01 Dec 2010
BMS partners with dance troupe
Bristol-Myers Squibb is to partner with the renowned African-American dance company Alvin Ailey American Dance Theatre to raise awareness about HIV/AIDS
02 Dec 2010
FDA panel votes against GSK cancer drug
Advisors to the US FDA have recommended against approval of GSK's Avodart (dutasteride) for the additional indication of reduction of the risk of prostate cancer in high-risk populations
02 Dec 2010
Pfizer's Sutent gets extra EC approval
Pfizer's Sutent has received European approval for a new indication in the treatment of progressive pancreatic Neuroendocrine tumours (NET)
02 Dec 2010
EMA relaxes public access to documents
The European Medicines Agency (EMA) has relaxed its policy on access to documents related to medicines for human and veterinary use
02 Dec 2010